Deficiency for endoglin in tumor vasculature weakens the endothelial barrier to metastatic dissemination

File(s)

Deficiency for endoglin in tumor vasculature weakens the endothelial barrier to metastatic dissemination..pdf (4.05 MB)

Published version

Show more

Author(s)

Anderberg, C

Cunha, SI

Zhai, Z

Cortez, E

Pardali, E

more

Type

Journal Article

Date Issued

2013-03-11

Citation

Journal of Experimental Medicine, 2013, 210 (3), pp.563-579

URI

http://hdl.handle.net/10044/1/21808

DOI

https://www.dx.doi.org/10.1084/jem.20120662

ISSN

1540-9538

Publisher

Rockefeller University Press

Start Page

563

End Page

579

Journal / Book Title

Journal of Experimental Medicine

Volume

210

Issue

3

Copyright Statement

© 2013 Anderberg et al. This article is distributed under the terms of an
Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six
months after the publication date (see http://www.rupress.org/terms). After six
months it is available under a Creative Commons License (Attribution–Noncommercial–
Share Alike 3.0 Unported license, as described at http://creativecommons.org/
licenses/by-nc-sa/3.0/).

License URL

https://creativecommons.org/licenses/by-nc-sa/3.0/

Identifier

http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000315997000011&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202

Subjects

Science & Technology

Life Sciences & Biomedicine

Immunology

Medicine, Research & Experimental

Research & Experimental Medicine

IMMUNOLOGY

MEDICINE, RESEARCH & EXPERIMENTAL

HEREDITARY HEMORRHAGIC TELANGIECTASIA

PANCREATIC NEUROENDOCRINE TUMORS

TGF-BETA-RECEPTOR

ANTI-ANGIOGENIC THERAPY

RENAL-CELL CARCINOMA

HUMAN SOLID TUMORS

ANTIANGIOGENIC THERAPY

GROWTH-FACTOR

MOUSE MODEL

HETEROZYGOUS MICE

Publication Status

Published